Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

FABIOR 0.1% FOAM

tazarotene
$12.3228per GM

Strength

1 mg/g

Manufacturer

Mayne Pharma

NDC

51862029510

Classification

Brand

Dosage Form

AEROSOL, FOAM

Route

TOPICAL

Last Updated

4/22/2026

Active Ingredients

TAZAROTENE

Approval Type

New Drug (NDA)

FDA Application

NDA202428

On Market Since

3/10/2017

Pharmacological Classes

Retinoid
Retinoids

Price History

1W

0.0%

1M

-1.3%

3M

-1.2%

6M

-1.2%

1Y

-0.4%

3Y

N/A

5Y

N/A

All

+4.6%

Generic Alternatives

Save up to 35%

2 alternatives • Same active ingredient

TAZAROTENE 0.1% GEL
Generic
00713080431•Cosette Pharmaceuticals, Inc.
$7.9700
Save 35%
TAZAROTENE 0.1% GEL
Generic
45802044294•Padagis Israel Pharmaceuticals Ltd
$7.9700
Save 35%

Related Drugs

Same classification

DIFFERIN 0.1% GEL
Brand
00299491045•Galderma Laboratories, L.P.
$0.4639
per GM
DIFFERIN 0.1% GEL
Brand
00299491015•Galderma Laboratories, L.P.
$0.7045
per GM
RETIN-A 0.05% CREAM
Brand
00187516245•Bausch Health US LLC
$0.7904
per GM
RETIN-A 0.025% CREAM
Brand
00187516045•Bausch Health US LLC
$0.7904
per GM
RETIN-A 0.025% CREAM
Brand
00187516020•Bausch Health US LLC
$0.7907
per GM
RETIN-A 0.05% CREAM
Brand
00187516220•Bausch Health US LLC
$0.7914
per GM
RETIN-A 0.01% GEL
Brand
00187517245•Bausch Health US LLC
$0.9570
per GM
RETIN-A 0.025% GEL
Brand
00187517045•Bausch Health US LLC
$0.9582
per GM
RETIN-A 0.025% GEL
Brand
00187517015•Bausch Health US LLC
$0.9592
per GM
RETIN-A 0.1% CREAM
Brand
00187516420•Bausch Health US LLC
$0.9594
per GM

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy